GHIT Fund: New investment of about 1.37 billion yen for new drug development for malaria and neglected tropical diseases

GHIT Fund announced that it has decided to invest a total of about 1.37 billion yen in seven new drug developments for malaria, Chagas disease, schistosomiasis, soil-transmitted parasite disease, Buruli ulcer, and cutaneous leishmaniasis. Did.